JP2006501202A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006501202A5 JP2006501202A5 JP2004523753A JP2004523753A JP2006501202A5 JP 2006501202 A5 JP2006501202 A5 JP 2006501202A5 JP 2004523753 A JP2004523753 A JP 2004523753A JP 2004523753 A JP2004523753 A JP 2004523753A JP 2006501202 A5 JP2006501202 A5 JP 2006501202A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- independently
- group
- alkylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10233817A DE10233817A1 (de) | 2002-07-25 | 2002-07-25 | Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| PCT/EP2003/007891 WO2004011438A1 (de) | 2002-07-25 | 2003-07-18 | Diarylsubstituierte cyclische harnstoffderivate mit mch-modulatorischer wirkung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006501202A JP2006501202A (ja) | 2006-01-12 |
| JP2006501202A5 true JP2006501202A5 (https=) | 2006-08-31 |
| JP4568113B2 JP4568113B2 (ja) | 2010-10-27 |
Family
ID=30128364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004523753A Expired - Fee Related JP4568113B2 (ja) | 2002-07-25 | 2003-07-18 | Ｍｃｈ調節作用を有するジアリール置換環状尿素誘導体 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1551810B1 (https=) |
| JP (1) | JP4568113B2 (https=) |
| AR (1) | AR040514A1 (https=) |
| AT (1) | ATE535513T1 (https=) |
| AU (2) | AU2003257465A1 (https=) |
| BR (1) | BR0312916A (https=) |
| CA (1) | CA2493924A1 (https=) |
| DE (1) | DE10233817A1 (https=) |
| IL (1) | IL166471A (https=) |
| MX (1) | MXPA05001048A (https=) |
| MY (1) | MY142551A (https=) |
| PE (1) | PE20040702A1 (https=) |
| TW (1) | TW200408627A (https=) |
| WO (2) | WO2004012648A2 (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7241787B2 (en) | 2004-01-25 | 2007-07-10 | Sanofi-Aventis Deutschland Gmbh | Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments |
| DE102004003811A1 (de) * | 2004-01-25 | 2005-08-11 | Aventis Pharma Deutschland Gmbh | Substituierte N-Cyclohexylimidazolinone, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US8372848B2 (en) * | 2004-03-23 | 2013-02-12 | Mixture Sciences, Inc. | Melanin-concentrating hormone receptor antagonists and methods of use |
| WO2006015279A1 (en) * | 2004-07-28 | 2006-02-09 | Neurogen Corporation | Heterocyclic diamine compounds as ligands of the melanin concentrating hormone receptor useful for the treatment of obesity, diabetes, eating and sexual disorders |
| EP1634598A1 (en) * | 2004-09-07 | 2006-03-15 | Laboratorios Del Dr. Esteve, S.A. | Use of piperazine derivatives and analogues for the manufacture of a medicament for the prophylaxis and/or treatment of disorders of food ingestion |
| WO2007063760A1 (ja) * | 2005-11-30 | 2007-06-07 | Mitsubishi Chemical Corporation | 有機化合物、電荷輸送材料、電荷輸送材料用組成物および有機電界発光素子 |
| JP5250967B2 (ja) * | 2005-11-30 | 2013-07-31 | 三菱化学株式会社 | 有機化合物、電荷輸送材料、電荷輸送材料用組成物および有機電界発光素子 |
| US8329704B2 (en) | 2005-12-21 | 2012-12-11 | Janssen Pharmaceutica, N.V. | Substituted pyrazinone derivatives for use in MCH-1 mediated diseases |
| WO2007093365A2 (en) * | 2006-02-15 | 2007-08-23 | Sanofi-Aventis | Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| JP2010500300A (ja) | 2006-08-08 | 2010-01-07 | サノフィ−アベンティス | アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用 |
| EP2102208B1 (en) | 2006-12-05 | 2014-04-23 | Janssen Pharmaceutica NV | Novel substituted diaza spiro pyridinone derivatives for use in mch-1 mediated diseases |
| WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| DE102008049675A1 (de) | 2008-09-30 | 2010-04-01 | Markus Dr. Heinrich | Verfahren zur Herstellung von 3-Aminobiphenylen |
| WO2010047982A1 (en) | 2008-10-22 | 2010-04-29 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| JP5557845B2 (ja) | 2008-10-31 | 2014-07-23 | メルク・シャープ・アンド・ドーム・コーポレーション | 糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体 |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| MX2012001729A (es) | 2009-08-26 | 2012-06-13 | Sanofi Sa | Nuevos hidratos cristalinos de fluoroglicosido heteroaromatico, productos farmaceuticos que comprenden estos compuestos, y su empleo. |
| US8895596B2 (en) | 2010-02-25 | 2014-11-25 | Merck Sharp & Dohme Corp | Cyclic benzimidazole derivatives useful as anti-diabetic agents |
| BR112013021236B1 (pt) | 2011-02-25 | 2021-05-25 | Merck Sharp & Dohme Corp | composto derivado de benzimidazol, e, composição |
| EP2683698B1 (de) | 2011-03-08 | 2017-10-04 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| US8895547B2 (en) | 2011-03-08 | 2014-11-25 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
| EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2683701B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683702B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| RU2465895C1 (ru) * | 2011-09-08 | 2012-11-10 | Государственное образовательное учреждение высшего профессионального образования "Мордовский государственный университет им. Н.П. Огарева" | Способ лечения депрессивного невроза |
| US9527875B2 (en) | 2012-08-02 | 2016-12-27 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| RU2015140066A (ru) | 2013-02-22 | 2017-03-30 | Мерк Шарп И Доум Корп. | Противодиабетические бициклические соединения |
| WO2014139388A1 (en) | 2013-03-14 | 2014-09-18 | Merck Sharp & Dohme Corp. | Novel indole derivatives useful as anti-diabetic agents |
| BR112015031291A2 (pt) | 2013-06-20 | 2017-07-25 | Bayer Cropscience Ag | derivados de sulfureto de arila e derivados de arilalquil sulfóxido como acaricidas e inseticidas |
| WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| US10752588B2 (en) | 2014-12-19 | 2020-08-25 | The Broad Institute, Inc. | Dopamine D2 receptor ligands |
| WO2016100940A1 (en) | 2014-12-19 | 2016-06-23 | The Broad Institute, Inc. | Dopamine d2 receptor ligands |
| US11072602B2 (en) | 2016-12-06 | 2021-07-27 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
| WO2018118670A1 (en) | 2016-12-20 | 2018-06-28 | Merck Sharp & Dohme Corp. | Antidiabetic spirochroman compounds |
| EP3902805A4 (en) | 2018-12-28 | 2023-03-01 | SPV Therapeutics Inc. | CYCLINE-DEPENDENT KINASE INHIBITORS |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0002649A3 (en) * | 1977-12-19 | 1979-07-11 | Sandoz Ag | 1-dimethyl-substituted alkyl-2- or 4-substituted phenylimidazoles, their production and their use as anti-obesity agents |
| DE4107857A1 (de) * | 1991-03-12 | 1992-09-17 | Thomae Gmbh Dr K | Cyclische harnstoffderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| WO1996025410A1 (en) * | 1995-02-17 | 1996-08-22 | Takeda Chemical Industries, Ltd. | Azole compounds, their production and use |
| FR2764889B1 (fr) * | 1997-06-20 | 2000-09-01 | Sod Conseils Rech Applic | Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
| AU757488B2 (en) * | 1998-03-25 | 2003-02-20 | Bristol-Myers Squibb Company | Imidazolone anorectic agents: III. heteroaryl derivatives |
| JP2002003370A (ja) * | 1999-09-20 | 2002-01-09 | Takeda Chem Ind Ltd | メラニン凝集ホルモン拮抗剤 |
| JP2004516239A (ja) * | 2000-07-06 | 2004-06-03 | ニューロジェン コーポレイション | メラニン凝集ホルモン受容体リガンド |
| MXPA03000923A (es) * | 2000-07-31 | 2003-06-09 | Smithkline Beecham Plc | Compuestos de carboxamida y su uso como antagonistas de un receptor 11cby humano. |
| PY0117895A (es) * | 2000-07-31 | 2003-11-03 | Pfizer Prod Inc | Derivados de imidazol |
| YU52403A (sh) * | 2000-12-26 | 2006-03-03 | Dr.Reddy's Research Foundation | Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže |
| GB0200283D0 (en) * | 2002-01-08 | 2002-02-20 | Smithkline Beecham Plc | Compounds |
-
2002
- 2002-07-25 DE DE10233817A patent/DE10233817A1/de not_active Withdrawn
-
2003
- 2003-07-15 AU AU2003257465A patent/AU2003257465A1/en not_active Abandoned
- 2003-07-15 WO PCT/EP2003/007639 patent/WO2004012648A2/de not_active Ceased
- 2003-07-18 EP EP03771060A patent/EP1551810B1/de not_active Expired - Lifetime
- 2003-07-18 WO PCT/EP2003/007891 patent/WO2004011438A1/de not_active Ceased
- 2003-07-18 AU AU2003251001A patent/AU2003251001B9/en not_active Ceased
- 2003-07-18 AT AT03771060T patent/ATE535513T1/de active
- 2003-07-18 BR BR0312916-0A patent/BR0312916A/pt not_active IP Right Cessation
- 2003-07-18 MX MXPA05001048A patent/MXPA05001048A/es active IP Right Grant
- 2003-07-18 CA CA002493924A patent/CA2493924A1/en not_active Abandoned
- 2003-07-18 JP JP2004523753A patent/JP4568113B2/ja not_active Expired - Fee Related
- 2003-07-21 PE PE2003000725A patent/PE20040702A1/es not_active Application Discontinuation
- 2003-07-23 MY MYPI20032759A patent/MY142551A/en unknown
- 2003-07-23 TW TW092120029A patent/TW200408627A/zh unknown
- 2003-07-23 AR AR20030102644A patent/AR040514A1/es unknown
-
2005
- 2005-01-17 IL IL166471A patent/IL166471A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006501202A5 (https=) | ||
| JP2006517563A5 (https=) | ||
| JP2021534124A5 (https=) | ||
| JP2004538259A5 (https=) | ||
| AU9189301A (en) | Use of substituted imidazo(1,2-A)pyridine-, imidazo(1,2-A)pyrimidine and imidazo(1,2-A)pyrazine-3-YL-amine derivatives for producing NOS-inhibiting medicaments | |
| TW200500358A (en) | Compounds | |
| MY146279A (en) | Compounds affecting glucokinase | |
| EP1489077A4 (en) | 2- FURANCARA ACID HYDRATES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | |
| SE0102299D0 (sv) | Compounds | |
| SE0102300D0 (sv) | Compounds | |
| ATE361287T1 (de) | Neue indol-2-on derivate | |
| RU2007134380A (ru) | Антибактериальные производные пиперидина | |
| JP2009526795A5 (https=) | ||
| JP2008526999A5 (https=) | ||
| JP2007507494A5 (https=) | ||
| BRPI0413393A (pt) | fexofenadina, composição farmaceuticamente aceitável, método de tratamento antihistamìnico, composição, processo para preparar fexofenadina e uso de fexofenadina | |
| JP2017520530A5 (https=) | ||
| JP2009526792A5 (https=) | ||
| ES2443342T3 (es) | Combinación de inhibidor de la HMG-CoA reductasa rosuvastatina con un inhibidor de la fosfodiesterasa 4, tal como roflumilast, roflumilast-N-óxido para el tratamiento de enfermedades pulmonares inflamatorias | |
| JP2011516511A5 (https=) | ||
| KR20210008070A (ko) | 신경 섬유 감작과 연관된 질환의 치료를 위한 1,3-티아졸-2-일 치환된 벤즈아미드 | |
| NO20070837L (no) | Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer. | |
| JP2018526391A5 (https=) | ||
| RU2006130000A (ru) | Органические соединения | |
| TW202003487A (zh) | 經取代的２，２＇—聯嘧啶基化合物、其類似物及其使用方法 |